CorMedix

CRMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$583.682 M

$7.44 -0.93%

Close of 7 Aug 2026

Revenue

$311.7M

#2120 by revenue

Earnings

$163.1M

#1093 by earnings

Shares outstanding

79,050,395

Latest filing cover page

P/E ratio

3.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#197AltimmuneALT$599.0M
#198VerastemVSTM$592.3M
#199CorMedixCRMD$583.7M
#200ArvinasARVN$572.1M
#201Contineum TherapeuticsCTNM$565.8M

Where these numbers come from

Share counts and financials for CorMedix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.